Serum caspase-1 levels in metastatic melanoma patients: Relationship with tumour burden and non-response to biochemotherapy

Melanoma Research

Volumn 12, Issue 4, 2002, Pages 343-348

  Mouawad, R ^a   Antoine, E C ^a   Gil Delgado, M ^a   Khayat, D ^a   Soubrane, Claude ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Biochemotherapy; Metastatic melanoma; Serum caspase 1

Indexed keywords

CISPLATIN; INTERLEUKIN 1BETA CONVERTING ENZYME; RECOMBINANT ALPHA2A INTERFERON; RECOMBINANT INTERLEUKIN 2; ALPHA INTERFERON; ANTINEOPLASTIC AGENT; BIOLOGICAL RESPONSE MODIFIER; INTERLEUKIN 2; LACTATE DEHYDROGENASE; RECOMBINANT PROTEIN; TUMOR MARKER; TUMOR PROTEIN;

ADULT; AGED; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC VALUE; DISEASE COURSE; ENZYME BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MELANOMA; PRIORITY JOURNAL; TREATMENT OUTCOME; TUMOR VOLUME; BLOOD; DRUG RESISTANCE; ENZYMOLOGY; METASTASIS; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PATHOLOGY; PHYSIOLOGY;

ADULT; AGED; ANTINEOPLASTIC AGENTS; APOPTOSIS; BIOLOGICAL RESPONSE MODIFIERS; CASPASE 1; CISPLATIN; COMBINED MODALITY THERAPY; DISEASE PROGRESSION; DRUG RESISTANCE, NEOPLASM; FEMALE; HUMAN; INTERFERON-ALPHA; INTERLEUKIN-2; LACTATE DEHYDROGENASE; MALE; MELANOMA; MIDDLE AGE; NEOPLASM METASTASIS; NEOPLASM PROTEINS; RECOMBINANT PROTEINS; SUPPORT, NON-U.S. GOV'T; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL; HUMANS; L-LACTATE DEHYDROGENASE; MIDDLE AGED;

EID: 0036021005     PISSN: 09608931     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008390-200208000-00006     Document Type: Article

References (31)

1. Death substrates come alive
2. Caspases: Enemies within
3. Caspases: The executioners of apoptosis
4. Human ICE/CED-3 protease nomenclature
5. Ordering the cytochrome c-initiated caspase cascade: Hierarchical activation of caspases-2, -3, -6, -7, -8, and -10 in a caspase-9-dependent manner
6. A novel heterodimeric cysteine protease is required for interleukin-1 processing in monocytes
7. Role of interleukin-1 beta converting enzyme (ICE) in acute myelogenous leukemia cell proliferation and programmed cell death
8. Interleukin 1β-converting enzyme (caspase-1) is overexpressed in the adenocarcinoma of the pancreas
9. Inhibition of caspase-1 induces cell death in pancreatic carcinoma cells and potentially modulates expression levels of bcl-2 family proteins
10. A comparative study of Fas and Fas-ligand expression during melanoma progression
11. Plasma Fas ligand, an inducer of apoptosis, and plasma soluble Fas, an inhibitor of apoptosis, in advanced melanoma
12. Sequential chemoimmunotherapy with cisplatin, interleukin-2, and interferon alfa-2a for metastatic melanoma
13. Salpêtrière Hospital experience with biochemotherapy in metastatic melanoma
14. Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma
15. Proteases for cell suicide: Functions and regulation of caspases
16. Induction of apoptosis in fibroblasts by IL-1 beta-converting enzyme, a mammalian homolog of the C. elegans cell death gene ced-3
17. Macromolecular substrates for the ICE-like proteases during apoptosis
18. IL-18 regulates IL-1beta-dependent hepatic melanoma metastasis via vascular cell adhesion molecule-1
19. Interleukin-1 beta converting enzyme (ICE) is preferentially expressed in neuroblastomas with favourable prognosis
20. Reduced expression of ICE/caspase1 and CPP32/caspase3 in human hepatocellular carcinoma
21. Endogenous interleukin 6 levels in patients with metastatic malignant melanoma: Correlation with tumour burden
22. Prognostic factors in patients with metastatic malignant melanoma. A multivariate analysis
23. S100-Beta, melanoma-inhibiting activity, and lactate dehydrogenase discriminate progressive from nonprogressive American Joint Committee on Cancer stage IV melanoma
24. Association of bcl-2, bax, bcl-xL and interleukin-1 beta-converting enzyme expression with initial response to chemotherapy in acute myeloid leukemia
25. Involvement of caspases in 5-FU induced apoptosis in an oral cancer cell line
26. Caspase-dependent chemotherapy-induced death of glioma cells requires mitochondrial cytochrome c release
27. Interleukin-1 beta-converting enzyme mediates cisplatin-induced apoptosis in malignant glioma cells
28. Caspase-1 activity as a possible predictor of apoptosis induced by cisplatin in gastric cancer cells
29. Overexpression of caspase-1 (interleukin-1β converting enzyme) in chronic pancreatitis and its participation in apoptosis and proliferation
30. Loss of caspase-1 and caspase-3 protein expression in human prostate cancer